FDA Approves Scalp-Cooling For Chemo Hair Loss Final Trial

[News]

Dignitana, a world leader in medical scalp-cooling technology, has announced that it has received U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and is now free to initiate a highly anticipated multi-center, pivotal trial of the patented DigniCap® System...

More... (http://www.medicalnewstoday.com/releases/261704.php)